Nitric oxide decreases renal medullary Na+,K--ATPase activity through cyclic GMP-protein kinase G dependent mechanism

Journal of Physiology and Pharmacology

Volumn 54, Issue 2, 2003, Pages 191-210

  Bełtowski, Jerzy ^a   Marciniak, A ^a   Wojcicka G ^a   Gorny D ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cytochrome P450 dependent arachidonate metabolites; H+,K+ ATPase; Kidney; Na+,K+ ATPase; Nitric oxide; Protein kinase G

Indexed keywords

17 OCTADECYNOIC ACID; 8 BROMO CYCLIC GMP; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARGININE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYTOCHROME P450; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; KT 5823; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OUABAIN; SNARE PROTEIN; SPERMINE;

ABDOMINAL AORTA; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MICROSOME; NONHUMAN; RAT; RENAL ARTERY;

ANIMALS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; KIDNEY MEDULLA; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE; PENICILLAMINE; RATS; RATS, WISTAR;

EID: 0037789538     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 1997; 272: F561-F578.
2. Ortiz PA, Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol 2002; 282: F777-F784.
3. - transport by a cGMP-mediated mechanism ill the kidney proximal tubule. Am J Physiol 1997; 272: F242-F248.
4. Amorena C, Castro AF. Control of proximal tubule acidification by the endothelium of the peritubular capillaries. Am J Physiol 1997; 272: R691-R694.
5. Feraille E, Doucet A. Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: Hormonal control. Physiol Rev 2001; 81: 345-418.
6. McKee M, Scavone C, Nathanson JA. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 1994; 91: 12056-12060.
7. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994; 8: 436-439.
8. Linas SL, Repine JE. Endothelial cells regulate proximal tubule epithelial cell sodium transport. Kidney Int 1999; 55: 1251-1258
9. Syren ML, Tirelli AS, Assael BM, Sereni F. Regulation of sodium-potassium-adenosine triphosphatase activity by extracellular guanosine 3′,5′-cyclic monophosphate in rat kidney. Acta Physiol Scand 1996; 158: 295-296.
10. +-ATPase alpha1-subunit gene in an MTAL cell line. Am J Physiol 1999; 276: F614-F621.
11. Zeidel ML, Silva P, Brenner BM, Seifter JL. Cyclic GMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol 1987; 252: F551-F559.
12. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol 1996; 270: F106-F115.
13. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb chloride absorption by reducing Na(+)-K(+)-2Cl(-) cotransporter activity. Am J Physiol 2001; 281: F819-F825.
14. Stoos BA, Carretero OA, Garvin JL. Endothelial-derived nitric oxide inhibits sodium transport by affecting apical membrane channels in cultured collecting duct cells. J Am Soc Nephrol 1994; 4: 1855-1860.
15. +-ATPase in rat thich ascending limb of Henle. Kidney Int 1999; 55: 1819-1831.
16. +-ATPase. J Physiol 1999; 518: 37-46.
17. +-ATPase inhibition by atrial natriuretic factor in rat renal medulla. J Physiol Pharmacol 1998; 49: 271-283.
18. Younes-Ibrahim M, Barlet-Bas C, Buffin-Meyer B, Cheval L, Rajerison R & Doucet A. Ouabain-sensitive and -insensitive K-ATPases in rat nephron: effect of K depletion. Am. J. Physiol. 1995; 268: F1141-F1147.
19. Buffin-Meyer B, Younes-Ibrahim M, Barlet-Bas C, Cheval L, Marsy S & Doucet A. K depletion modifies the properties of Sch-28080-sensitive K-ATPase in rat collecting duct. Am J Physiol. 1997; 272, F124-F131.
20. +-ATPase activity. Acta Biochim Pol 2002; 49; 515-527.
21. Lowry OH, Rosenbrough NI, Farr AL., Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. +-ATPase activity. J Physiol Pharmacol 2002; 53: 210-231.
23. +-ATPase activity by angiotensin II in rat proximal tubules. Am J Physiol 2001; 280: F474-F479.
24. Scavone C, Scanlon C, McKee M., Nathanson JA. A trial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J Pharmacol Exp Ther 1995; 272: 1036-1043.
25. Kang DG, Kim JW, Lee J. Effects of nitric oxide synthesis inhibition on the na,k-atpase activity in the kidney. Pharmacol Res 2000; 41: 121-125.
26. +-ATPase in opossum kidney cells. Kidney Int 1999; 56: 627-634.
27. +-ATPase in opossum kidney cells. Am J Physiol 1999; 277: F859-F865.
28. Guzman NJ, Fang MZ, Tang SS, Ingelfinger JR, Garg LC. Autocrine inhibition of Na,K-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 1995; 95: 2083-2088.
29. Boldyrev AA, Bulygina ER, Kramarenko GG, Vanin AF. Effect of nitroso compounds on Na/K-ATPase. Biochim Biophys Acta 1997; 1321: 243-251.
30. -ATPase α-subunit phosphorylation by a cAMP-dependent signalling pathway in intact cells from rat kidney cortex. FEBS Lett 1996; 396: 309-314.
31. Sweadner KJ, Feschenko MS. Predicted location and limited accessibility of protein kinase A phosphorylation site on Na,K-ATPase. Am J Physiol 2001; 280: C1017-C1026.
32. +-ATPase. Am J Physiol 1995; 269: F673-F680.
33. Slobodyanski E, Aoki Y, Gaznabi AKM, Aviles DH, Fildes RD, Jose PA. Dopamine and protein phosphatase activity in renal proximal tubules. Am J Physiol 1995; 268: F279-F284.
34. +-ATPase in renal tubule cells. Proc Natl Acad Sci UDSA 1989; 86: 8068-8072.
35. Fryckstedt J, Aperia A, Snyder G, Meister B. Distribution of dopamine- and cAMP-dependent phosphoprotein (DARPP-32) in the developing and mature kidney. Kidney Int 1993; 44: 495-502.
36. Higuchi E, Nishi A, Higashi H, Ito Y, Kato H. Phosphorylation of protein phosphatase-1 inhibitors, inhibitor-1 and DARPP-32, in renal medulla. Eur J Pharmacol 2000; 408: 107-116.
37. +-ATPase activity in renal tubule cells. Proc Natl Acad Sci USA 1991; 88: 2798-2801.
38. Snyder GR, Girault JA, Chen YJC et al. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus. Regulation by factors other than dopamine. J Neurosci 1992; 12: 3071-3083.
39. Tsou K, Snyder GL, Greengard P. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra. Proc Natl Acad Sci USA 1993; 90: 3462-3465.
40. Eklof AC, Holtback U, Svennilson J, Fienberg A, Greengard P, Aperia A. Increased blood pressure and loss of ANP-induced natriuresis in mice lacking DARPP-32 gene. Clin Exp Hypertens 2001; 23: 449-460.
41. Satoh T, Cohen HT, Katz AI. Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids. J Clin Invest 1993; 91: 409-415.
42. Satoh T, Cohen HT, Katz AI. Different mechanisms of renal Na-K-ATPase regulation by protein kinases in proximal and distal nephron. Am J Physiol 1993; 265: F399-F405.
43. Bełtowski J, Górny D, Marciniak A Atrial natriuretic factor (ANF) inhibits renal Na,K-ATPase through cytochrome P450 dependent arachidonate metabolites. Prostaglandins Leukot Essent Fatty Acids 1996; 55 (Suppl 1): P232.
44. Sun CW, Alonso-Galicia M, Taheri MR, Falck JR, Harder DR, Roman RJ. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. Circ Res 1998; 83: 1069-1079.
45. Laycock SK, Vogel T, Forfia PR et al. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 1998; 82: 1263-1271
46. Harder DR, Narayanan J, Birks EK et al. Identification of a putative microvascular oxygen sensor. Circ Res 1996; 79: 54-61.
47. 2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 2001; 59: 230-237.
48. Lopez B, Moreno C, Salom MG, Roman RJ, Fenoy FJ. Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide. Am J Physiol 2001; 281: F420-F427.
49. Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC. Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 1999; 104: 1131-1137.
50. Feraille E, Barlet-Bas C, Cheval L et al. Presence of two isoforms of Na, K-ATPase with different pharmacological and immunological properties in the rat kidney. Pflugers Arch 1995; 430: 205-212.
51. --ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway. Am J Physiol 2000; 279: C1685-C1693.
52. +-ATPase activity through cyclic GMP pathway in proximal rat trachea. Eur J Pharmacol 1999; 367: 307-314.
53. Pontiggia L, Vinterhalter K, Gloor SM. Inhibition of Na,K-ATPase activity by cGMP is isophorm-specific in brain endothelial cells. FEBS Lett 1998; 436: 466-470.
54. Lucking K, Nielsen JM, Pedersen PA, Jorgensen PL. Na-K-ATPase isoform (alpha 3, alpha 2, alpha 1) abundance in rat kidney estimated by competitive RT-PCR and ouabain binding. Am J Physiol 1996; 271: F253-F260.
55. Heyman SN, Karmeli F, Rachmilewitz D, Hai-Yehia A, Brezis M. Intrarenal nitric oxide monitoring with Clark-type electrode: Potential pitfalls. Kidney Int 1997; 51: 1619-1623.